Detalhe da pesquisa
1.
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis.
Eur Respir J
; 59(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34949698
2.
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India.
Open Forum Infect Dis
; 9(2): ofab615, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35097152
3.
Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant "XDR" tuberculosis patients on bedaquiline during COVID-19 pandemic.
Lung India
; 38(1): 98-99, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33402651